Log In
BCIQ
Print this Print this
 

PIKA rabies vaccine

  Manage Alerts
Collapse Summary General Information
Company Yisheng Biopharma Co. Ltd.
DescriptionRabies vaccine with a double-stranded RNA analog (PIKA) adjuvant that acts as a toll-like receptor 3 (TLR3) agonist
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationRabies
Indication DetailsPost-exposure prophylaxis of rabies infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today